from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1817/-

LFCtreatmentdescriptionclass of inhibitor

0.078

Amikacinug/mL Amikacintranslation

0.298

Cap5-10ug/mL Capreomycintranslation

0.308

Rox10-50 ug/mL Roxithromycintranslation

-0.796

SM2-5 ug/mL Streptomycintranslation

-0.971

Tet5-10 ug/mL Tetracyclinetranslation

0.412

Rif0.2-5ug/mL Rifampicintranscription

0.359

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.058

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.889

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

1.038

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.436

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.264

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.486

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.525

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.874

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.470

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.265

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.506

KCN5-20 ug/mL Potassium cyaniderespiration

1.374

NaN30.2-2 mM Sodium aziderespiration

-1.401

Nigericin50 uM Nigericinrespiration

0.400

TRC10-150 ug/mL Triclosanrespiration

1.101

TRZ10-25 ug/mL Thioridazinerespiration

-1.934

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.547

menadione6-10 ug/mL Menadionerespiration

1.063

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.377

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-1.231

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.324

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.929

NRP_1Non-replicating persistence stage 1dosRassociated

0.244

Amp0.2mg/mL AmpicillincellWall

0.566

Cephalexin20-100 ug/mL CephalexincellWall

0.098

Cerulenin0.32-5 ug/mL CerulenincellWall

0.756

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.413

EMB10-20 ug/mL EthambutolcellWall

-0.141

Eta12-40 ug/mL EthionamidecellWall

-0.585

INH0.2-0.4 ug/mL IsoniazidcellWall

0.177

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.502

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.496

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.241

BZA0.12 mg/mL BenzamidearomaticAmides

-0.237

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.191

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.032

H2O24 mM hydrogen peroxideDNAdamaging

-0.200

Levo10 ug/mL LevofloxacinDNAdamaging

0.197

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.873

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.568

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.386

UVUV-irradiationDNAdamaging

0.125

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.048

Antimycin12.5-50 ug/mL Antimycin A?

-1.738

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.181

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.264

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.037

PA8240.2-2 ug/mL PA-824?

1.005

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.266

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.062

Verapamil50 uM Verapamil?

-0.964

mercaptoethanol2 mM 2-Mercaptoethanol?

0.889

methoxatin10-20 ug/mL Methoxatin?